IDEOS Vācija - vācu - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

ideos

laboratoire innotech international (8135484) - calciumcarbonat; colecalciferol - kautablette - teil 1 - kautablette; calciumcarbonat (00058) 1,25 gramm; colecalciferol (00615) 10 mikrogramm

Totylem Vācija - vācu - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

totylem

laboratoire innotech international (8135484) - filmtablette - 60 mg/0,4 mg

Oenothera biennis UT Vācija - vācu - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

oenothera biennis ut

deutsche homöopathie-union dhu-arzneimittel gmbh & co. kg. (3115488) - oenothera biennis (pot.-angaben) - urtinktur - oenothera biennis (pot.-angaben) (17960) 1 milliliter

OENOTHERA BIENNIS D3 Vācija - vācu - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

oenothera biennis d3

deutsche homöopathie-union dhu-arzneimittel gmbh & co. kg. - oenothera biennis (pot.-angaben) - flüssige verdünnung zur injektion - oenothera biennis (pot.-angaben) 1.0ml

OENOTHERA BIENNIS D1 Vācija - vācu - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

oenothera biennis d1

deutsche homöopathie-union dhu-arzneimittel gmbh & co. kg. - oenothera biennis (pot.-angaben) - streukügelchen - oenothera biennis (pot.-angaben) 1.0g

OENOTHERA BIENNIS UT Vācija - vācu - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

oenothera biennis ut

staufen-pharma gmbh & co.kg - oenothera biennis (pot.-angaben) - urtinktur - oenothera biennis (pot.-angaben) 1.0ml

Brukinsa Eiropas Savienība - vācu - EMA (European Medicines Agency)

brukinsa

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - antineoplastische mittel - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).

Oenothera biennis Šveice - vācu - Swissmedic (Swiss Agency for Therapeutic Products)

oenothera biennis

boiron sa - oenothera biennis - tm, d; tm, d - homöopathisch

Oenothera biennis Šveice - vācu - Swissmedic (Swiss Agency for Therapeutic Products)

oenothera biennis

boiron sa - oenothera biennis - lm/q1, d; k30, d - homöopathisch

Oenothera biennis Šveice - vācu - Swissmedic (Swiss Agency for Therapeutic Products)

oenothera biennis

boiron sa - oenothera biennis - tropfen / spray, trinkampullen, globuli, tabletten, trituration / pulver - tm, d; tm, d - homöopathisch